C12Q 2525/10
Modifications characterised by
C12Q2525/10 (Modifications characterised by) appears on 741 US grants and 1,125 published applications in this corpus.
Search patents in C12Q- Granted patents
- 741
- Published applications
- 1,125
- Assignees
- 420
- Inventors
- 1,726
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 5 | 0 |
| 2000 | 6 | 0 |
| 2001 | 6 | 2 |
| 2002 | 4 | 9 |
| 2003 | 3 | 8 |
| 2004 | 2 | 5 |
| 2005 | 4 | 8 |
| 2006 | 4 | 6 |
| 2007 | 0 | 7 |
| 2008 | 3 | 7 |
| 2009 | 5 | 9 |
| 2010 | 6 | 17 |
| 2011 | 9 | 19 |
| 2012 | 13 | 33 |
| 2013 | 15 | 34 |
| 2014 | 20 | 39 |
| 2015 | 23 | 41 |
| 2016 | 32 | 47 |
| 2017 | 41 | 65 |
| 2018 | 44 | 118 |
| 2019 | 51 | 111 |
| 2020 | 72 | 124 |
| 2021 | 73 | 102 |
| 2022 | 71 | 99 |
| 2023 | 74 | 59 |
| 2024 | 48 | 63 |
| 2025 | 50 | 58 |
| 2026 | 56 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Q 2525/191Incorporating an adaptorIndexing code208
- C12Q 2525/186Incorporating a non-extendable or blocking moietyIndexing code116
- C12Q 2525/161Incorporating target specific and non-target specific sitesIndexing code104
- C12Q 2525/117Incorporating modified baseIndexing code101
- C12Q 2525/179Incorporating arbitrary or random nucleotide sequencesIndexing code97
- C12Q 2525/155Incorporating/generating a new priming siteIndexing code82
- C12Q 2525/101Incorporating non-naturally occurring nucleotidesIndexing code53
- C12Q 2525/207Sirna, mirnaIndexing code45
All 25 subgroupsShow fewer
- C12Q 2525/197Incorporating a spacer/coupling moietyIndexing code40
- C12Q 2525/185Incorporating bases where the precise position of the bases in the nucleicIndexing code39
- C12Q 2525/204Specific length of the oligonucleotidesIndexing code37
- C12Q 2525/113Incorporating modified backboneIndexing code34
- C12Q 2525/151Repeat or repeated sequencesIndexing code34
- C12Q 2525/205AptamerIndexing code31
- C12Q 2525/125Incorporating agents resulting in resistance to degradationIndexing code29
- C12Q 2525/173Incorporating a polynucleotide runIndexing code29
- C12Q 2525/107Incorporating a peptide nucleic acidIndexing code16
- C12Q 2525/131Incorporating a restriction siteIndexing code14
- C12Q 2525/121Incorporating both deoxyribonucleotides and ribonucleotidesIndexing code13
- C12Q 2525/143Incorporating a promoter sequenceIndexing code11
- C12Q 2525/119Incorporating abasic sitesIndexing code10
- C12Q 2525/203Incorporating a composite nucleic acid containing a polypeptide sequence other than pnaIndexing code8
- C12Q 2525/15Incorporating a consensus or conserved sequenceIndexing code5
- C12Q 2525/149Incorporating a coding sequenceIndexing code2
- C12Q 2525/137Incorporating/modifying moieties to eliminate restriction sitesIndexing code0
Recent patents
- 3′ protected nucleotides6 Oct 2026US 12,753,201 B2Roche Sequencing Solutions, Inc.
- Method for quantifying and/or detecting human male DNA6 Oct 2026US 12,753,430 B2Qiagen GmbH
- Varietal counting of nucleic acids for obtaining genomic copy number information6 Oct 2026US 12,753,435 B2Cold Spring Harbor Laboratory
- RNA sequencing method for the analysis of b and t cell transcriptome in phenotypically defined b and t cell subsets6 Oct 2026US 12,753,436 B2Centre National de la Recherche Scientifique (CNRS)
- Detection and prediction of infectious disease6 Oct 2026US 12,753,448 B2Karius, Inc.
- Nucleic Acid Sequence Analysis from Single Cells8 Oct 2026US 2026/0308573 A1Illumina, Inc.
- Linked ligation1 Oct 2026US 2026/0297658 A1Ncan Genomics, Inc.
- Linked ligation1 Oct 2026US 2026/0297659 A1Ncan Genomics, Inc.
- Methods and Enzymatic Compositions for Forming Libraries of Adapter Ligated Nucleic Acid Molecules3 Sep 2026US 2026/0258484 A1New England Biolabs, Inc.
- Particle-based isolation of proteins and other analytes27 Aug 2026US 2026/0250748 A1Nautilus Subsidiary, Inc.
Most cited
By later US patents
- Labelled nucleotides1,103US 7,057,026 B2Solexa Limited · 2006
- PNA-DNA-PNA chimeric macromolecules416US 5,700,922 AIsis Pharmaceuticals, Inc. · 1997
- Massive parallel method for decoding DNA and RNA382US 6,664,079 B2The Trustees of Columbia University in the City of New York · 2003
- Methods for making single molecule arrays355US 8,133,719 B2Callida Genomics, Inc. · 2012
- Process for synthesizing nucleic acid318US 6,410,278 B1Eiken Kagaku Kabushiki Kaisha · 2002